The Organization of European Cancer Institutes (OECI) is a non-government, non-profit Organisation founded in Vienna in 1979. Presently The OECI regroups more than 70 cancer Institutes across Europe, including the Regina Elena National Cancer Institute – IRCCS IRE.
The OECI aims to promote cooperation among European Cancer Institutes, in order to:
- create a critical mass of expertise and competence that can identify and share new and better models of care
- improve the quality of cancer care and translational research
- improve patients’ quality of life
- provide a continuous process of improvement in order to make uniform the cancer patients’ treatment according to quality standards shared across Europe.
- promote the development of European multicenter studies and the use of EU funds for research.
The OECI, on Semptember 10th 2015, certified that the Regina Elena National Cancer Institute – IRE, meets the quality standards for cancer care and research and it is therefore designed as a Comprehensive Cancer Center, that is an oncological IRCCS with special features such as translational research, multidisciplinary, continuous improvement of care, the production of guidelines and clinical pathways, continuous education and patient empowerment.
Coordinator and Contact Person OECI:
Dr. Stefano Canitano
Dr.ssa G. Caolo
Dr.ssa A. Di Turi
Dr.ssa E. Papa
Dr.ssa A. C. Pignatelli
Centro di Riferimento Oncologico Istituto Nazionale Tumori, Aviano
Azienda Ospedaliera Universitaria San Martino
IST- Istituto Nazionale per la Ricerca sul Cancro, Genova
Istituto Europeo di Oncologia, Milano
Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano, Milano
Istituto Nazionale Tumori Regina Elena, Roma
Istituto Oncologico Veneto IRCCS-IOV, Padova
Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico, Bari
Istituto Nazionale Tumori -IRCCS "Fondazione G.Pascale" (INT-Pascale), Napoli
IRCCS, Centro di Riferimento Oncologico della Basilicata (CROB), Rionero in Vulture
Azienda Ospedaliera Arcispedale S. Maria Nuova IRCCS, Reggio Emilia
Ospedale San Raffaele (OSR), Milano
European School of Oncology (ESO), Milano
IFOM - FIRC Institute of Molecular Oncology, Milano
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori [IRST]-IRCCS, Meldola - Forlì
IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano
Ente Ospedaliero Ospedali Galliera, Genova
Nerviano Medical Sciences Group S.r.l., Nerviano
For a list of all members OECI: http://www.oeci.eu/Member_List.aspx
- Preliminary designation and presentation of the Institutional Project Plan. The process begins with a first collection of qualitative and quantitative data, required from the OECI, in order to obtain a preliminary designation of the Institute.
- Self assessment. A period of six months during which the Institute compiles a qualitative and a quantitative questionnaires, prepares the required documents and organizes the peer review.
- Peer review. An OECI team visits the Institute for two days, during which checks the received data.
- Reporting. After the peer review visit, the team sends a report with strengths and opportunities for the Institute and indications for the improvement plan.
- Improvement Action Plan. The Institute, following the OECI instructions, develops an improvement action plan.
- Approval Accreditation and Designation Certificate. The final accreditation decision will be taken by the OECI A&D Board within 1 month after the OECI received the improvement plan of the institute.
- Follow up. One year after the peer review visit the cancer institute provides a written report with the progress of the goals, actions and time-schedule set in the improvement plan. The OECI A&D Board may organize a visit to evaluate the improvement plan.
The certificate is valid for four years.